St Vincent's University Hospital

Mr Abdulla is currently an oncoplastic breast surgery fellow at St Vincent's University Hospital in Dublin, Ireland. He qualified in 2016 from Royal College of Surgeons in Ireland. In 2023, he completed his postgraduate surgical training in Bahrain, with board-certification in general surgery. His research interests include axillary management in breast cancer and de-escalation of axillary surgery.

The Royal Marsden NHS Foundation Trust

Sarah has been a Breast Cancer Clinical Nurse Specialist at the Royal Marsden for 12years and is the Lead at the Chelsea site of the hospital. After graduating from Middlesex University, she gained a Diploma in Cancer Nursing in 2006 and a BSc in Cancer Oncology in 2008.

In 2020 Sarah gained a place on the Florence Nightingale Windrush Leadership programme. She previously served as the chairperson for Breast Cancer Now’s Breast Care Nurses Younger Women Champions, a group of specialist nurses working collaboratively and sharing experience and good practice to improve the services and experiences of younger women going through breast cancer. She was instrumental in organising the first conference in London for Black Women and Breast Cancer in 2019 and has continued to run yearly since.
In 2022 she helped to launch a range of ‘softies’ in a variety of skin tones to be worn under a bra after a mastectomy, an innovation within the NHS for the first time. This work has been greatly recognised and won 2 prestigious national awards in 2024 – Laing Buisson Rising Star and HSJ NHS Race Equality Award partnered by NHS Race & Health Observatory. She has featured in podcasts produced by the charity Black Women Rising and Womanthology with a focus on raising awareness and the experiences of cancer.  And was among the Joseph Fashion Portraits series in 2023 celebrating International Women’s Day. 
Areas of interests are – health inequalities/ethnic minorities, younger women, and genomics.

The Christie NHS Foundation Trust

Anne Armstrong graduated from Bristol University in 1995. She trained in Medical Oncology at The Christie Hospital, Manchester, taking up a Consultant post there in 2007, specialising in breast cancer. She is actively involved in both clinical and laboratory-based research, with a focus on immunotherapy, having completed a PhD at the University of Manchester in 2002. She is the Chief Investigator of the LION study, investigating the addition of COX-inhibitors to standard of care immunotherapy in breast, renal and lung cancer.  

She also has an interest in breast cancer in young women, including fertility preservation and pregnancy as well as survivorship issue. She is currently the Clinical Lead for the RCOG Green Top Guideline Pregnancy and Breast Cancer update and a Clinical Advisor for the NICE Menopause: diagnosis and management update. She was the Clinical Lead for the 2018 NICE early and locally advanced breast cancer guideline update. She is a member of the Executive Committee the UK Breast Cancer Group.

Chesterfield Royal Hospital NHS Foundation Trust

Laura is a Nurse Consultant in the Breast Team at Chesterfield Royal Hospital NHS Foundation Trust. She has been a qualified nurse for 25 years gaining a BA(Hons) in Nursing Studies from Sheffield Hallam in 2000. She then went on to gain an MSc in Advanced Clinical Practice in 2021.

She worked to a senior nursing level in the Oncology setting for several years before taking a career break and working for a short period of time in New Zealand.

Following this she worked as a Breast Research Sister for 10 years, before then working as an ACP in the Breast Oncology Team.

Her interests are research, teaching and health promotion.

In her most recent job as a Nurse Consultant at Chesterfield, where she has worked for just over 2 years, she works in the Breast Surgical Team. She runs fast track clinics with referrals from GP, breast cancer follow-up and has set up an endocrine management clinic which she really enjoys. Her particular area of interest is exercise and healthy lifestyle. She has carried out research while working in Oncology on the benefit of exercise and now promotes this in other aspects of her work.

East Lancashire Hospitals NHS Trust

University Hospitals Birmingham NHS Foundation Trust

Salena Bains is a Consultant Oncoplastic Breast Surgeon at the Queen Elizabeth Hospital, UHB and graduated from University of Leicester in 2002. She completed a PhD in Breast cancer-related lymphoedema at King’s College London in 2015 and was a TIG fellow before taking on her consultant post in Birmingham. Salena is lead breast sarcoma surgeon and clinical lead for breast surgery in UHB.

Cambridge University Hospitals NHS Foundation Trust

Professor Benson is a Consultant Breast Surgeon at Addenbrooke’s Hospital, Cambridge, Associate Lecturer, University of Cambridge and Visiting Professor, School of Medicine, Anglia Ruskin University, Cambridge, UK. He has published widely in the field of breast diseases with authorship of more than 160 papers and has written/edited 7 books on breast cancer/reconstructive surgery (ranked in the top 0.084% of the world’s breast cancer experts). He is a former member of the Planning Committee for the San Antonio Breast Cancer Symposium (2013 – 2015) and was a Trustee/member of the Executive Board of ABS until demitting from office in 2021.

Croydon University Hospital

Royal United Hospital Bath

Professor Mark Beresford is a Consultant Clinical Oncologist at the Dyson Cancer Centre, Royal United Hospital Bath and has a Visiting Chair at the University of Bath. He specialises in the treatment of breast and urological cancers. He is a graduate of both Cambridge and Oxford Universities and undertook his specialist oncology training in London (UCLH, Charing Cross and Mount Vernon Hospitals).

Professor Beresford has a DM from Oxford University for research into the assessment of response to chemotherapy using functional imaging techniques. He is author of over 60 peer-reviewed publications and is Chief Investigator on numerous national and international clinical trials.

Professor Beresford advises NICE at scoping meetings and Technology Appraisals. He is a member of the Clinical Oncology Professional Support and Standards Board for the Royal College of Radiologists and chairs the RCR Management for Oncologists course. He is a committee member of the British Uro-oncology Group (BUG) and Cancer Research @ Bath. He chairs the West of England Breast Cancer Site Specific Group, is Cancer Research Lead for the South West and has served two terms as vice-chair of the CRUK Population Research Committee. He is co-founder and co-chair of the UK Breast Cancer Group (UKBCG).

Breast Cancer Now

Dr Cath Biddle is a digital strategy expert with a background in psychology. After beginning her career as a health psychologist, she transitioned into the digital space 25 years ago, applying a human behaviour-led approach to understanding how people engage with technology.

Dr Biddle has worked across commercial and charitable sectors, helping organisations connect with their audiences in meaningful ways. Her expertise lies in developing digital experiences that provide genuine value to the user, meeting them where they are, fostering trust, and strengthening engagement and brand advocacy.
In her session, Dr Biddle will explore the growing trend of people turning to social media for health information and the increasing risks posed by misinformation, as platforms like Meta step down fact-checking.

Royal College of Surgeons of England

Whiston Hospital, Mersey and West Lancashire Teaching Hospitals NHS Trust

University Hospitals Bristol and Weston NHS Foundation Trust

Jeremy is an Associate Professor and Consultant Medical Oncologist in Bristol, specialising in breast and germ cell cancers. In addition to his clinical work, he works part time for the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) and as a Clinical Adviser for NICE.

Newcastle Upon Tyne Hospitals NHS Trust

Henry Cain qualified in 2001 from Leicester Medical School. Following the award of MD in breast cancer signalling pathways and higher surgical training in Newcastle upon Tyne he spent a year as the Oncoplastic Fellow at the Canniesburn Unit in Glasgow. He was appointed a Consultant Oncoplastic Surgeon at the Royal Victoria Infirmary Newcastle upon Tyne in 2013. Henry Cain was the surgical QUIPP lead for the introduction of day case mastectomy pathway to the Royal Victoria Infirmary.  Henry Cain continues a commitment in teaching advanced oncoplastic breast surgery.  Driving improvements in surgical care he has led the introduction of Radioactive Seed Localisation of impalpable breast cancer and post neo-adjuvant chemotherapy I125 seed Targeted Axillary Dissection to the UK.  With a significant recruitment into national trials he is the surgical lead Co-Investigator for the NOSTRA trial and the Chief Investigator for the PRE-DX national RCT.

Champalimaud Foundation, Lisbon, Portugal

Maria-João Cardoso is the Director of the Breast Cancer Research Program and Breast Surgeon at the Champalimaud Foundation Breast Unit, in Lisbon Portugal and Associate Professor of the University of Lisbon Faculty of Medicine.  She is the Coordinator and PI of the EU Horizon 2022 funded CINDERELLA Project [HORIZON-HLTH-2021-DISEASE-04-04. HORIZON-RIA. Proposal number 101057389], Until 2024, she has published more than 120 papers on international journals, with an h index of 47 and also co-authored more than 300 full communications in major national and international conferences. Since 2011 she is president of a Support Centre for Breast Cancer Patients, Mama Help, cooperating actively in European advocacy training like EUROPA DONNA. She is a member of the board of the Portuguese Society of Senology  and of the Faculty of ESO and ESMO.

ABS President

Miss Leena Chagla is the President of the Association of Breast Surgery and past-President of the Liverpool and Northwest Society of Surgeons. She heads the breast unit at St Helens and Knowsley Teaching Hospitals which is actively involved in clinical innovation and trials. She continues to publish regularly in peer reviewed journals.

Leena qualified from Grant Medical College, Mumbai, with a gold medal in Surgery. Whilst in India, she trained at the Sir JJ Hospital and at the Tata Memorial Cancer Centre. Her passion for surgical oncology developed in those formative years.

She is a popular speaker both nationally and internationally and is involved in the development of guidelines for the management of breast cancer. She is passionate about MDT working and she launched the Anti-bullying Campaign (#CoreItOut) for ABS in alliance with RCSEd. She represented ABS on the pathology Big 18 and the organising committee of Symposia Mammographicum.

Leena was instrumental in setting up the International Forum at ABS with a view to sharing good practice globally.  She is committed to improving and standardising Breast cancer care through education and training. She is an Educational Supervisor for the National Oncoplastic Fellow and she is a Professional Clinical Advisor for screening to Public Health England.

Outside of work Leena is a keen sportswoman having played water-polo for Maharashtra, Liverpool and the Northern Counties at the highest level.

Great Western Hospitals NHS Foundation Trust

Ms Anushka Chaudhry is a Consultant Oncoplastic and Cosmetic Breast Surgeon in Wiltshire. Being at the forefront of breast cancer care, she combines surgical expertise with a deep commitment to advocacy and education.  She is also Acting Deputy Chief Medical Officer of her hospital trust. 

In addition to her clinical work, Anushka serves as the chair of a young women's breast cancer charity, Aurora Breast Cancer Wellbeing, where she spearheads initiatives to support and empower those affected by breast cancer. 

Driven by a passion for equity in healthcare, Anushka is deeply involved in efforts to reduce inequalities in breast cancer treatment among ethnic minorities. Through educational outreach, community engagement, and advocacy campaigns, she works tirelessly to raise awareness and address systemic barriers to care. 

As an educator, Anushka shares her knowledge and expertise with colleagues, students, and the public. Through lectures, workshops, and mentorship programs, she inspires the next generation of healthcare professionals to prioritize compassion and advocacy in their practice.

Barts Cancer Centre

Dr John Conibear graduated from the University Hospital of Wales in 2001 and completed his post-graduate general medical training in The Barts and The London Training rotation in 2006. Before gaining his substantive post as a consultant clinical oncologist in St. Bartholomew’s Hospital in 2014, he completed a 2-year fellowship with the NCRI Radiotherapy Trials Quality Assurance Group in Mount Vernon Hospital. During his fellowship he conducted research into techniques to improve clinician target outlining during radiotherapy planning and was subsequently awarded a MD(Res) from UCL in 2018.

Dr Conibear is currently the clinical director for thoracic and neuro-oncology in St.Bartholomew’s Hospital, the stereotactic radiotherapy lead for HCA UK, the Elekta MRL breast sub-group chair, and the oncology clinical lead for the National Lung Cancer Audit (NLCA). Dr Conibear was past Deputy Medical Director of Barts Cancer Centre and interim Divisional Director for clinical support services in Barts Cancer Centre.

Dr Conibear specialises in all the non-surgical treatments for both breast and lung cancers. He has expertise in chemotherapy, biological therapy, immunotherapy, radiotherapy, and state of the art radiotherapy techniques. Dr Conibear is also trained in using state of the art radiotherapy technologies and techniques including MR guided radiotherapy, Accuray Cyberknife, Leksell Icon Gamma Knife and Proton Therapy. These technologies are often used to deliver stereotactic ablative body or brain radiotherapy (SABR / SRS).

University of Southampton and University Hospital Southampton

Ellen Copson is Professor of Medical Oncology and Honorary Medical Oncology Consultant at the University of Southampton where she specialises in the treatment of early and advanced breast cancer.
Ellen trained in medical oncology in London and Southampton, receiving her CCT in 2009. Following a PhD studying heritable breast cancer, Ellen developed a particular interest in genomic and nutritional factors which influence breast cancer outcomes. She is lead oncologist of the POSH UK cohort study of young breast cancer patients and of the CANDO3 study of body composition and chemotherapy toxicity. Ellen is principle investigator for a number of observational and interventional clinical trials in early and advanced breast cancer and clinical advisor to several cancer survivorship studies. Ellen is chair of the World Cancer Research Fund Global Cancer Survivorship expert panel and co-chair of the UK Breast Cancer Studies Group working group on lifestyle interventions.  Ellen founded the national Breast Cancer Trainees Research Collaborative Group  and has been a member of the UKBCG executive committee since 2023.

Ellen has been co-chair of the Wessex Molecular Tumour Board since 2017 and cancer lead of the Central and South Central Genomic Laboratory Hub since  2021. She is oncology lead for Health Education England’s “GeNotes” genomics information resource and is involved in a number of other national educational initiatives in cancer genomics. Locally, Ellen is oncology lead for the University of Southampton medical degree course.

University College London

University of Southampton and University Hospital Southampton NHS Foundation Trust

Ramsey Cutress is Professor of Breast Surgery and Consultant Surgeon at the University of Southampton and University Hospital Southampton. Ramsey is topic advisor for the NICE Early and Locally Advanced Breast Cancer Guideline (NG101) and was a member of the writing group for the ABS BAPRAS Oncoplastic Breast Reconstruction Guidelines and is co-director of the ABS Advanced Skills in Breast Disease Management Course. His clinical research interests include breast cancer in young women as a member of the POSH study research team and the investigation of patient and host determinants of breast cancer outcomes including genetic predisposition, immunological and lifestyle factors. He is currently involved in various national research studies and clinical trials including the EndoNET HTA funded trail of neo-adjuvant endocrine therapy. He is breast sub-specialty editor for the Annals of the Royal College of Surgeons of England and a member of the CPS committee of ABS.

Manchester University NHS Foundation Trust

Rajiv is a consultant surgeon in the Nightingale & Genesis Breast Cancer Prevention Centre, at Wythenshawe Hospital, which is recognised as one of the largest Breast symptomatic and screening units in the UK. This is a recognised centre of excellence, providing complex oncoplastic breast surgery and leading on new technology. His specialist surgical training, which spanned over 10 years, includes a TIG Oncoplastic fellowship in Manchester, and an International Fellowship (Breast, Endocrine and Melanoma) in Melbourne, Australia.

Liverpool University Hospitals

National Centre for Integrative Oncology (NCIO)

Nazanin Derakhshan is a Professor of Experimental Psychology and Head of the Centre for Post-Traumatic Growth  and Resilience at the National Centre for Integrative Oncology (NCIO) in the UK. 

Her research focuses on the social and cognitive neuroscience of anxiety and depression and the development of interventions promoting resilience in vulnerable populations. She has held prestigious fellowships, published over 100 papers in renowned international academic journals, supervised numerous PhD students, and has served on editorial boards of several journals in her field. She is an active advocate for public engagement and the dissemination of science in practice.

She is the founder of the award winning psycho-educational Centre for Building Resilience in Breast Cancer (BRiC), where she has translated her research to help thousands of women affected by breast cancer rebuild resilience in survivorship.

Macclesfield District General Hospital

Miss Rania Diab is a final-year medical student at the University of Buckingham with a strong passion for pursuing a career in oncoplastic breast surgery. She has delivered national presentations and actively participated in surgical electives to enhance her clinical experience and skills.

In addition to her academic achievements, Rania is of Palestinian heritage and speaks three languages: Arabic, Hebrew, and English. She contributed to a study at Macclesfield District General Hospital alongside the breast surgery team, exploring the correlation between metabolic syndrome and the aggressiveness of breast cancer. Her multicultural background has been a motivating factor in her career aspirations, particularly given the high prevalence of metabolic syndrome in the Middle East, enabling her to raise awareness and promote primary prevention, supporting individuals with risk factors exposure. 

University of Oxford

David Dodwell is a senior clinical oncologist working in Oxford Population Health in The University of Oxford and Oxford University Hospitals NHS Trust. He has a 20+-year special interest in the management of breast cancer. He is co-oncology lead for the new national breast cancer audits, is involved in many epidemiological studies in breast cancer and works within The Early Breast Cancer Trialists’ Collaborative Group (EBCTCG).

James Paget Healthcare NHS Trust

Ms Downey qualified from Nottingham University in the last century and she undertook SHO training in Bristol, Research in Breast Cancer Oncology in Manchester and Registrar training in Yorkshire. Her first consultant post in Bradford for 4 years and moved to East Anglia in 2005. Sarah's first involvement in RCS was examiner for MRCS at time OSCE introduced. Acted on committee and then Chair of Court of Examiners for RCS England. Part of training committee since came to East Anglia in 2005. Undertook Divisional Director role in own hospital for 5 years – opened new daycase unit. Acted as regional Breast Screening QA Surgeon for 6 years. Joined SAC in 2015 and became regional TPD in 2018. Currently Chair of General Surgery SAC.  Undergraduate PBL tutor and online tutor for oncoplastic MS. Director of Screening for own Trust and also Clinical Appraisal Lead. Former TIG Chair and faculty on Advanced Breast Cancer Course. Currently Honorary Secretary of ABS.

University of Southampton

Diana Eccles is Professor of Cancer Genetics at the University of Southampton and Honorary Consultant Clinical Geneticist in the Wessex Regional Genetics Service (University Hospital Southampton). Her research background is in molecular genetics and genetic epidemiology, her clinical training in general medicine, oncology and clinical genetics. As a new consultant in 1995, she established one of the first cancer genetics clinical services in the UK with a strong research focus. She is Chief Investigator of a large UK prospective cohort study of early onset breast cancer. Her clinical academic leadership roles include Director of the Southampton Clinical Trials Unit (2009-2014), Head of the School of Cancer Sciences (2015-2018) and currently Dean of the Faculty of Medicine, University of Southampton since 2018.

Wythenshawe Hospital

Katy is a Nurse Consultant in Breast at the Nightingale Breast Unit, Manchester Foundation Trust. Katy qualified as a registered nurse in 1996 and began her professional career in theatres before becoming a Surgical Care Practitioner. In 2006 Katy undertook a masters module in advanced skills in breast care before undertaking the Advanced Clinical Practice Msc at the University of Central Lancashire. Katy was a Lead Clinical Nurse Specialist in Breast care for 10 years in Stockport, a unit which supported newly diagnosed breast cancer patients through to palliative care. Since 2019 Katy has worked at MFT, initially in the role of Advanced Nurse Practitioner and more recently as a Nurse Consultant. In 2021 Katy was awarded, along with a colleague, the National Nursing Times Award in Cancer Care for the implementation of a telephone assessment clinic for breast pain. Katy’s current role is 50% clinical and 50% research and she is currently working towards her PhD.

Katy is passionate about her role as a nurse and the value that nursing brings to a patients experience.

St George's Hospital, London

Imperial College

Manchester Foundation Trust

Veneto Institute of Oncology, Padua, Italy

Manchester University NHS Foundation Trust

Ashu Gandhi works as a Consultant Breast Surgeon in Manchester. He has previously served the ABS in a variety of roles and is current Chair of the NHS BSP Screening Audit Committee.

Bolton NHS Foundation Trust

Clare Garnsey graduated from the University of Edinburgh and completed post-graduate training in Edinburgh, Glasgow and Manchester. She completed an oncoplastic fellowship at The Royal Marsden, London, before gaining a consultant position at Bolton NHS Foundation Trust. Clare is Associate Medical Director and Clinical Lead for breast cancer at the Greater Manchester Cancer Alliance and teaches as part of the breast faculty at the University of Manchester.

Clare’s interests include improving equity of access to high quality care within the NHS cancer system, standardisation of patient pathways, primary and secondary care collaboration and medical education, including development of the non-medical workforce. As Associate Medical Director of the Greater Manchester Cancer Alliance she is working to improve the visibility of metastatic patients in the NHS system and improve emergency and elective metastatic care.

IRCCS Humanitas Research Hospital, Italy

Medical University of Vienna

Dr Michael Gnant is Full Professor of Surgery at the Medical University of Vienna, Austria, where he also serves as President of the Austrian Breast & Colorectal Cancer Study Group. He is co-chairing and hosting the renowned St Gallen International Consensus Panel for Early Breast Cancer in Vienna since 2015.
Dr Gnant graduated in medicine in Vienna (1988) and subsequently specialized in surgery (1994) and surgical oncology. He also worked as a Visiting Scientist at the National Cancer Institute, National Institutes of Health, Bethesda, USA (1997–1999).
Dr Gnant’s research interests include several fields of surgical oncology, in particular breast and pancreatic cancer, immunotherapy, bone-targeted treatment for tumour micrometastases, tumor dormancy/quiescence and late relapse, pathway-directed therapies such as mTOR and CDK4/6 inhibition, SERDs, and he has been the Principal Investigator of many (N>30) clinical trials in these fields.
The author of more than 600 original peer-reviewed papers with an impact factor of 4,800 and an h-index of 90, Dr Gnant has presented over 1,000 lectures at national and international meetings. He is the recipient of multiple awards including the prestigious Claudia von Schilling Prize from the Medical University of Hannover, the Umberto Veronesi Lecture Award of Breast Surgery International, and a Corresponding Member of the Austrian Academy of Sciences. He holds an honorary MD degree of Sichuan University, Chengdu, China, and Honorary/Visiting Professorships of Tianjin Medical University, Jiaotong University Xi’an, and Nanjing Medical University in China. Repeatedly in recent years, he was among the most highly cited scientists worldwide.
Dr Gnant is involved in many scientific societies including ASCO, AACR, ACS, Breast International Group (BIG), EORTC, ESSO, EUSOMA and UICC. He served as an executive board member of BIG, is an independent reviewer and IDMC member for the EORTC, UICC and other international bodies, and is a scientific reviewer and process evaluator for the European Union. Dr Gnant is also Editor-in-Chief of BREAST CARE, and editorial board member and reviewer for many top-tier peer-reviewed journals including The Lancet, The New England Journal of Medicine, Journal of Clinical Oncology, and Annals of Oncology.

Champalimaud Foundation

Pedro Gouveia, MD, PhD, graduated in Medicine in 2004 at NOVA Medical School| Faculdade de Ciências Médicas (NMS|FCM), Portugal. He completed his General Surgery residency program in 2013 at Hospital de Matosinhos, after an Oncoplastic Breast Surgery Fellowship at the Paris Breast Center (2012/2013). During his residency program he has successfully designed and implemented a Walking Clinic and a Fast-Track program applied for upper GI and colorectal surgery. He is a board certified breast surgeon by the European Society of Surgical Oncology since 2015. In 2021, he received a PhD degree at Lisbon Medical School with the theme: 3D Digital Breast Cancer Surgery with Augmented Reality. Invited Assistant Professor at Lisbon Medical School since September 2022. Member of the European Society of Surgical Oncology Education and Training Committee - Breast working group - since October 2022. Head of the new Digital Surgery LAB at Champalimaud Foundation since December 2022. Invited Assistant Professor and coordinator of the optional curricular unit of Introduction to the Practice of Artificial Intelligence in Medicine at Lisbon Medical School (FMUL) since 2023.

Pedro is a dedicated breast specialist, medicalXR researcher and futurist at the Breast Unit of the Champalimaud Foundation, Lisbon, Portugal since 2013. Pedro is also the Oncoplastic Breast Consortium Coordinator for Portugal since 2019 and member of the Senology Portuguese Society since 2017. Member of the European Society of Surgical Oncology Education and Training Committee - Breast working group - since October 2022.

He has authored and co-authored several papers on international journals and authored two book chapters. He has also authored several communications in medical and technological conferences.

He is Associate Editor of Clinical Surgical Oncology journal since 2022 and Artificial Intelligence Surgery journal editor. He is reviewer for The Breast Journal and World Journal of Surgery.

Pedro’s research interests include breast cancer, oncoplastic breast surgery, breast reconstruction, 3D breast modelling, surgical breast simulation, augmented reality, connected care/health, big data, artificial intelligence and 5G network with edge computing.

Marmara University School of Medicine

Prof. Bahadir M. Gulluoglu works at Marmara University School of Medicine, Department of General Surgery since 1991 and he is currently a full-time professor (tenured) at the same institution since 2009. He formerly served as the Vice-Coordinator and Head-Coordinator for clinical graduate medical education at Marmara University. Prof. Gulluoglu has been a member of his university's Institutional Review Board since 2011. He also serves as a faculty member at Emil Palade University of Medicine, Pharmacy, Science and Technology, Targu Mures, Romania and the University of Kragujevac, Serbia. Prof. Gulluoglu is the co-founder of Marmara University Hospital, Breast Center, a member of the Breast Centres Network. Prof. Gulluoglu also works as a core faculty member at the European Academy of Senology (EAoS), the International Breast Ultrasonography School (IBUS), the European School of Oncology (ESO) and MANOSMED Mediterranean University of Mastology. He holds honorary fellowships from both the European Board of General Surgery and Breast Surgery. Besides, he works as a member of the BRESO (European Breast Surgical Oncology Certification) Structure Working Group. Prof. Gulluoglu is currently the academic leader of SENATURK (Senology Academy-Turkiye) and country coordinator of the Oncoplastic Breast Consortium (OPBC), Basel, Switzerland. He formerly served at the UEMS Breast Surgery Division of the European Board of Surgery and Senologic International Society (SIS) as deputy secretary, the Committee for National Breast Cancer Screening at the Turkish Ministry of Health as the chair and the American Society of Clinical Oncology (ASCO) Resource-Stratified Guideline Advisory Group as a panel member. Besides, Prof. Gulluoglu is an honorary member of the Bulgarian Surgical Society, the Romanian Society for Breast Surgery and Oncology and the Association of Breast Surgeons of India (ABSI). He is the founding executive member of the Turkish Society of Breast Surgery and the institutional research coordinator of the EORTC Breast Cancer Group. He is also the program chair of SENATURK’s International “Multidisciplinary Breast Health Care & Advanced Breast Cancer Surgery” Fellowship Program in Istanbul. Prof. Gulluoglu is the co-chair of the International Istanbul Breast Cancer Conference (Breastanbul) and (Turkish) National Health Quality Forum (USKAF). He is the convenor of Istanbul Reconstructive Breast Cancer Surgery (IREBS), Breast Surgical Ultrasound (SENUS), Breast Cancer Surgery Essentials (BRESSENTIAL) Workshops and Board of Directors member at biannual Breastics24h virtual meetings. Prof. Gulluoglu currently serves as the associate editor at Breast Care (Karger).

Glan Clwyd Hospital, Betsi Cadwaladr Local Health Board

Dr Anu Gunavardhan was appointed as a Consultant Histopathologist at Glan Clwyd Hospital, North Wales, in 2016. She has specialist interest in breast pathology and dermatopathology. Dr Gunavardhan is the Lead Breast Pathologist for the Betsi Cadwaladr Health Board and Quality Assurance Pathologist for Breast Test Wales.

Dr Gunavardhan participated in digital pathology validation and has various publications and audits on digital pathology. Currently leading AI project for breast pathology reporting at Betsi Cadwaladr Health board.

She is also Chair of the Wales Regional Council for Royal College of Pathologists, provides professional leadership, helps maintain and develop high-quality pathology services at a national level, and promotes the College through various initiatives.

Royal Surrey NHS Foundation Trust

Kent Oncology Centre

Dr Catherine Harper-Wynne completed her medical oncology training at The Royal Marsden Hospital and has worked at the Kent Oncology Centre since 2004. She is an Honorary Senior Clinical Lecturer at the Universities of Kent and Kent and Medway Medical School, supporting post-graduate students involved in basic research into triple negative breast cancer and novel methods of evaluating the axilla. Her other research interests include lifestyle and exercise in breast cancer and bone health in breast cancer and she has published widely.

She continues clinical research locally and nationally as Principal and Chief Investigator (CI) of many breast cancer trials such as CI for PALOMA2 involving the CDK4/6 inhibitor palbociclib and  new oral SERDs in HeredERA and PersevERA.

At regional and national level she was joint site specific lead of the Kent Surrey and Sussex breast cancer research group and is a member of the new UK Breast Cancer Studies Group where she is co-chair of the lifestyle and exercise sub-group.  

She was breast cancer lead on the National Health Service of Engalnd clinical advisory group, Chairing the group producing the Best Practice Timed Pathway document for early breast cancer and until recently and  was the regional SACT lead. Over the pandemic as a member of the National Cancer Policy Covid Group, she developed testing and vaccination protocols for patients. She is currently co-chair of the UK Breast Cancer Group (UKBCG).

BAPRAS

Paul Harris is a well-known plastic surgeon based in Central London, specialising in aesthetic and reconstructive breast surgery. He is a Past-President of the British Association of Aesthetic Plastic Surgeons (BAAPS) having served on Council in various positions for over 12 years.

Paul worked at The Royal Marsden Hospital for 15 years where he led on the development of the microvascular breast reconstruction service and created a standalone plastic surgery department. Since leaving the Royal Marsden and the National Health Service in 2018, Paul has directed his efforts more towards aesthetic breast surgery.

Mr Harris has published widely on both aesthetic and reconstructive breast surgery. He is regularly invited to lecture Nationally and Internationally, and is passionate about improving safety in cosmetic surgery. This has been through his work at the BAAPS and he also served as UK National Secretary for ISAPS between 2016 & 2019, and as the Aesthetic Lead for the British Association of Plastic, Reconstructive, and Aesthetic Surgeons (BAPRAS). He also works closely with several industry partners including Mentor as a Global Advisory Panel member. He is an Honorary Lecturer at University College, London where he teaches in aesthetic surgery.

Leeds Teaching Hospitals NHS Trust

Dr Sue Hartup is a Clinical Academic Consultant Nurse in Breast Research within the Breast Unit and Research & Innovation departments of Leeds Teaching Hospitals NHS Trust. She is an active member of the ABS Academic & Research committee and the Nursing committee, the EORTC QoL group and the UK Breast Cancer Clinical Studies Group. Sue has published on many subjects and is a member of various trial management groups and trial steering committees. She was an NIHR Doctoral Fellow and is a current Senior Clinical and Practitioner Award (NIHR SCPRA) holder. She specialises in developing research studies covering post-surgical pain, self-management interventions, survivorship, quality of life and patient outcomes. She is the research nurse lead for West Yorkshire & Harrogate Cancer Alliance and is a CancerSMART champion, teaching and educating about cancer in the community. Recently awarded an RfPB grant to continue her work in digital interventions for supporting breast cancer post-surgery care, and is Chief Investigator on 2 other current breast surgical studies.

Manchester University NHS Foundation Trust

Oncoplastic breast surgeon with research interests in commercial device studies.

Imperial College Healthcare NHS Trust

Yasmin Hassen is an ST7 Breast Trainee on the Northwest Thames Rotation. She completed her medical studies at Imperial College London and returned to Imperial during her early registrar training to complete a PhD in Patient Safety culminating in international presentations of her work as well as publications in leading journals. She currently serves as the vice chair of the Mammary Fold.

Beaumont Hospital

Professor Hill is the Dean of Medical Programmes and Professor and Chair of Surgery at the Royal College of Surgeons in Ireland. He graduated from UCD and did his surgical training in Dublin and London. He followed this with a two year fellowship at The Hospital of the University of Pennsylvania and the New York Hospital/Cornell Medical Center in the United States.

He returned to Ireland to do his Senior Registrar training on the National Training Programme.   Before taking up his position as Consultant he returned to the Sloan Kettering Cancer Centre to complete a Clinical Fellowship in Surgical Oncology.  

His clinical interests are in the area of breast cancer and melanoma.  His laboratory research interests are in the transcriptional control of breast cancer, in particular, the role of the coregulatory proteins

Professor Hill is the national advisor for surgical oncology for the National Cancer Control Programme.  His clinical practice is in Breast, General and Endocrine Surgery at Beaumont Hospital Dublin.  Professor Hill was a Council member and is a Past President of the Surgical Research Society.

University of Oxford

Robert Hills is Professor of Medical Statistics in the Nuffield Department of Population Health (NDPH) at the University of Oxford and head of the Secretariat for the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). He originally studied mathematics at Oxford, with a DPhil exploring algebraic  symmetries with applications to superconductivity. He joined the CTSU, now part of NDPH,  in 1993 as a programmer on the QUASAR trial in colorectal cancer. Following a brief period working in low temperature physics at the University of Nottingham, he moved to the University of Birmingham Clinical Trials Unit (BCTU) in 1997.There, he worked on clinical trials in Acute Myeloid Leukaemia, Alzheimer’s Disease, women’s health and many others as well as large scale individual patient data meta-analyses of treatment for colorectal cancer.
In 2006, he moved to Cardiff University as statistical lead for the NCRI/MRC trials in Acute Myeloid Leukaemia. During his 12 years in Cardiff he was head of the Haematology Clinical Trials Unit, and latterly led on clinical cancer research methodology and haematological malignancies. The novel designs used in the UK AML trials allowed an evaluation of the clinical value of disease monitoring, as well as numerous targeted therapies in designs that allow for an early change from an unpromising new therapy to one with greater potential. Additionally, he continued his work on the integration of laboratory and clinical data, and on individual patient data meta-analyses, where he demonstrated a survival benefit for gemtuzumab ozogamicin in AML. In 2018, he returned to NDPH as part of the EBCTCG.

Imperial College Healthcare NHS Trust

Ken Ho is a higher surgical trainee in Breast Surgery currently training at Charing Cross Hospital, Imperial College Healthcare NHS Trust. After completing medical school at Imperial College School of Medicine, he underwent run-through specialty training in General Surgery in North Central and East London, and North West London deaneries. Having worked in multiple breast units across the regions, Ken has developed a keen interest in oncoplastic breast procedures, reconstruction, and surgical innovation. He has presented research work at national and international conferences and published in peer-reviewed journals. In addition to clinical practice and research, Ken is actively engaged in surgical education and mentoring junior trainees. 

St James’s University Hospital Leeds

Breast Surgeon at St James’s University Hospital Leeds. Previous Honorary Secretary and President of The Association of Breast Surgery. Previous member of SAC, Chair NHS Breast Cancer Specialty Group, Extern M Sc Oncoplastic Breast Surgery University of East Anglia. Co-initiator of National Oncoplastic Fellowship Training Program, member of National Sentinel Node Training Faculty. Keen author and trialist. Chair Trial Steering Committee EndoNET. Surgical Lead National Breast Cancer Audits, Chair National Audit of Primary Breast Cancer (NAoPri) Audit Advisory Committee.

Barts Health NHS Trust

Royal Devon University Healthcare NHS Trust

Tom is the outgoing Chair of the Mammary Fold. He trained in the Southwest, and has recently undertaken a TIG fellowship in Leeds prior to starting his consultant post in Exeter. He has been the MF South West Peninsula Regional Representative, secretary to the Mammary Fold 2021-2023 and sat on the Mammary Fold Academic Committee.

Maidstone and Tunbridge Wells Hospital

Princess Anne Hospital, University Hospital Southampton

Goonj is a Consultant Oncoplastic Breast Surgeon based at the Princess Anne Hospital, University Hospital Southampton. She did her surgical training in India, specializing in Endocrine and Breast Surgery from Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, one of the most prestigious in the country.

Whilst working as a Consultant surgeon and Assistant Professor in India, Goonj qualified for the highly competitive International Fellowship in Oncoplastic and Reconstructive breast surgery at Wythenshawe Hospital and Nightingale Breast Centre, Manchester Foundation Trust. 

In her current role, Goonj, also serves as the Clinical Effectiveness Lead for breast surgery. She has led on multiple quality improvement projects, including digitalizing prescriptions and results templates, thereby, promoting sustainability and shortening patient pathways.  Her clinical interests include complex breast oncoplasty and reconstruction. Goonj has more than 40 publications and has been the recipient of National and International travel and research grants and awards, including the prestigious ICMR (Indian Council of Medical Research) and ELSA (Endoscopic and Laparoscopic Society of Asia) travel grant and best oral paper award.

Goonj enjoys teaching, training and delivering patient awareness talks. She contributes actively as OSCE examiner and ACC assessor. She has delivered lectures for surgical and oncology trainees in the North-West region and has been faculty on cadaveric courses. She has been invited as speaker on several National and International conferences and seminars.  Goonj frequently delivers patient awareness talks at the Maggie’s centre in Southampton.

Goonj is actively involved in research and clinical trials. She believes in collaborative research and is an active member of the National collaborative on establishing national guidance on idiopathic granulomatous mastitis (ENIGMA). She has been actively involved in patient recruitment for ongoing studies like EndoNET, POETIC-A, ATNEC and SMALL.

Uppsala University Hospital, Sweden

Royal Derby Hospital

Miss Monika Kaushik is a well-known Oncoplastic Breast Surgeon. She started as a Consultant Surgeon at University Hospitals of Leicester NHS Trust in 2013. She is highly experienced in modern management of breast cancer and leads on various research projects. She is also involved in senior leadership roles in management and education. Her passion is to improve widening participation for school students in medicine and is actively involved in various projects for this.

The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research

Dr Anna Kirby is a Consultant Clinical Oncologist in the UK specialising in the treatment of patients with breast cancer. She leads research into novel breast radiotherapy techniques at The Royal Marsden and Institute of Cancer Research (ICR), London. She was appointed as a Reader at the ICR in 2022. She is Technical Radiotherapy Lead for the UK Breast Proton Trial (PARABLE), Chief Investigator of the UK HeartSpare studies, Chief Clinical Co-ordinator of the IMPORT breast radiotherapy trials, and Breast Lead Investigator on the CORE trial evaluating the role of stereotactic radiotherapy in treating oligometastatic disease. 

Dr Kirby is current President of the European Society for Radiotherapy and Oncology (ESTRO) which facilitates radiation oncology research dissemination, education, training, interdisciplinary collaboration, professional support and advocacy across Europe and beyond.

Nightingale Breast Cancer Centre, Manchester, UK

Cliona is an Oncoplastic Breast Surgeon at the Nightingale Breast Cancer Centre in Manchester, UK. She studied medicine, including a BSc in the History of Medicine, at Charing Cross and Westminster Medical School, London and University College London. Her surgical training was in London, Bristol, Bournemouth, South Africa and Greater Manchester. She completed a PhD entitled ‘The Role of Procoagulants in Cancer and Chemotherapy Induced Venous Thromboembolism’ at the University of Manchester in 2006.

She delivers and teaches in all forms of oncoplastic breast surgery including reconstruction. At the University of Manchester, she leads the Cancer and Thrombosis Research Group, performing basic, translational and clinical research, investigating the symbiotic relationship between cancer and thrombosis. She also supervises MRes, MD and PhD students.

She is Chief Investigator on the TIP Trial and CHAMPion Study and surgical lead for LORIS, PRIMETIME, POETIC-A and FAST-Forward Boost and is on the Sloane Committee. Cliona leads the Association of Breast Surgery guideline development group for Idiopathic Granulomatous Mastitis and is a key member of the International Society of Haemostasis and Thrombosis guideline development group for VTE in breast cancer. She is Director of the North West Surgical Trials Centre, and mentors the North West Research Collaborative and North West Breast Research Collaborative. She also chairs the Scientific Committee for the Prevent Breast Cancer charity.

In her personal life, she enjoys dressmaking, knitting and endurance sports, having previously completed two Ironmans and the Everest Marathon.

University Hospitals of Leicester NHS Trust

Mr Jaroslaw Krupa graduated from Medical University of Warsaw and continued his postgraduate training at University College London Hospital and The Royal Marsden Hospital in London. He obtained his PhD in minimally invasive surgery and was awarded an Oncoplastic Surgery Fellowship at the National Institute of Cancer in Milan. In 2009 Mr Krupa was appointed to the post of Consultant Oncoplastic Breast Surgeon at University Hospitals of Leicester, one of the largest breast cancer centers in UK. He also obtained the role of the Head of Service for Breast Surgery (2015-2020) and title of Honorary Senior Lecturer in Leicester Cancer Research Centre. He co-authored publications and textbook chapters dedicated to various aspects of oncoplastic and reconstructive surgery and is actively involved in surgical training in these specialties.

University of Edinburgh

Professor Ian Kunkler is Honorary Professor of Clinical Oncology at the University of Edinburgh. He trained in Medicine at Cambridge University and St Bartholomew's Hospital , London and in Clinical Oncology at Edinburgh and Institut Gustave Roussy in Paris. His research interests are in clinical and translational trials of adjuvant radiotherapy in early breast cancer. He is Chief Investigator of the PRIME II and BIG 2.04 MRC SUPREMO trials. He is a past co-editor of Walter and Miller's Textbook of Radiotherapy and  has published over 100 peer reviewed papers.

Imperial College London

Ahmed Latif is a Breast Surgery registrar and is a Fellow of the Royal College of Surgeons of England and the European Board of Surgery. Coming towards the end of his surgical training, he is taking time out for research and is completing a PhD as a Darzi Fellow at the Institute of Global Health Innovation (IGHI), Imperial College London. His PhD focuses on the use of Wearable Technology in post Breast Cancer surgery upper-limb rehabilitation.

Imperial College Healthcare NHS Trust

Daniel is a Reader (Associate Professor) in Breast Surgery working in the Departments of BioSurgery and Surgical Technology, the Hamlyn Centre for Robotic Surgery and the Cancer Research UK Centre at Imperial College London. Daniel is Co-PI on the CRUK funded “REI-EXCISE” trial which seeks to validate a mass-spectrometry based intelligent knife or “iKnife” as an immediate margin detection system to improve the precision of breast conserving surgery, reduce re-operative intervention, and enhance
quality of life. He leads a UK wide team working on a CRUK-EPSRC funded project “MAMMOBOT” to design a flexible growing ductoscopic robot for early breast cancer detection. Daniel Co-Chairs the “Precision Therapy” theme of Imperial’s CRUK Centre and represents cancer surgery for the Imperial ECMC. He has published over 150 scientific papers in peer-reviewed journals on subjects relating to the application of surgical technologies, sensing and robotics to improve cancer surgery. His teams research has won national and international recognition, including the Hounsfield Prize, British Journal of Surgery Prize (ABS), Patey Prize (SARS), Sir Pat Forrest Award (BBG), Parasuraman Award, Athanasiou Medal (ABME), and the young scientist award nomination at MICCAI. He has attracted funding from Industry (Waters Corp, Hitachi Medical Corp), the Academy of Medical Sciences and Wellcome Trust, Engineering and Physical Sciences Research Council, Association of Breast Surgery, Cancer Research UK, and the National Institute for Health and Care Research.

Daniel won the Ronald Raven Prize Travelling Fellowship to learn from experts in Breast Cancer and Reconstructive Surgery at the MD Anderson Cancer Center, the forefront Cancer Center in USA, and more recently the Price Thomas Fellowship of the Travelling Surgeons of Great Britain and Ireland. More recently he won the highly prestigious James IV Travelling Association of Surgeons. He has delivered a number of key-note lectures including “McGuire Lecture in Surgical Oncology”(Queens University, Kingston, Canada).

NHS Lothian

James Lucocq is an ST5 Breast and General Surgery trainee who recently completed his PhD at the University of Dundee. He is currently undertaking a Master’s in Surgical Oncology, Reconstructive, and Aesthetic Breast Surgery. Passionate about collaborative research, he developed the Adeno-IPMN 1 and 2 collaboratives. He participates with the European Society of Surgical Oncology (ESSO), enjoys editorial work and contributes to the BJS Institute and Medical Xcelerator platforms.  He serves as a general surgeon in the Royal Army Medical Corps (RAMC).

Aintree University Hospitals NHS Foundation Trust

Peterborough City Hospital

John Mathew is a consultant breast surgeon with special interest in reconstruction and reshaping of the breast following cancer resection. He has previously done laboratory research into autoantibodies in cancer and earned Doctor of medicine from the University of Nottingham. He has made significant contributions to the literature in breast cancer research and oncoplastic aspects of breast cancer surgery. 

Queen's University Belfast

Stuart McIntosh is Professor of Surgical Oncology at Queen’s University in Belfast, and an honorary consultant breast surgeon at Belfast City Hospital.
 
He is an experienced breast cancer clinical trialist, with a particular interest in neoadjuvant, peri-surgical and treatment de-escalation studies. He is the Chief Investigator for the UK HTA-funded SMALL trial, a national phase III multicentre study comparing standard surgery with vacuum-assisted excision for the treatment of small screen-detected breast cancers. His translational research interests lie in the area of the DNA damage immune response in breast cancer.
 
He is a former chair of the national Cancer Research Institute’s Breast research Group, and is one of the Royal College of Surgeons Breast Surgical Specialty Leads, responsible for supporting the development and delivery of breast cancer surgical trials nationally.

University of Sheffield Medical School

Miss Jenna Morgan is an NIHR Advanced Fellow at the University of Sheffield and a Consultant Oncoplastic Breast Surgeon at Doncaster and Bassetlaw Teaching Hospitals NHS Trust. Her research interests include Shared Decision Making, Informed Consent and the Second Victim Syndrome with expertise in Qualitative and Mixed Methods Research. She currently sits on the Association of Breast Surgery's Academic and Research Committee and is on the steering committees of several large national and international trials, including SMALL, MARECA, the iBRA-NET Localisation studies and LOLIPOP.

Croydon University Hospital

Ms Akriti Nanda is a General Surgical Registrar in South West London and an NHS Clinical AI Fellow. With a medical school background from Oxford, she specialises in oncoplastic breast surgery research, AI in healthcare, and evidence-based surgery. She has multiple peer-reviewed publications, international presentations and conference awards for her research.

Royal Devon University Healthcare NHS Trust

Royal Marsden Hospital

Rachel is an oncoplastic breast surgeon at the Royal Marsden Hospital. She completed her surgical training within the London Deanery and a Royal College of Surgeons of England funded MD research degree at The Royal Marsden/Institute of Cancer Research, investigating improving cosmetic outcomes after breast cancer surgery. She completed an Oncoplastic Breast Surgery Fellowship at The Royal Marsden in 2020/1. Rachel’s research interests include improving surgical outcomes in breast cancer to improve the lives of women living with and beyond breast cancer and risk reduction surgery

President of Society of Irish Breast Surgeons

Royal Devon University Healthcare NHS Foundation Trust

University of Liverpool

Professor Carlo Palmieri graduated in anatomy and medicine from the University of London, later obtaining a PhD at Imperial College London. Prior to joining The Clatterbridge Cancer Centre, Professor Palmieri held the position of a senior Lecturer within the department of Cancer at Imperial College London and was a Consultant in Medical Oncology at Imperial College Healthcare NHS Trust, and was awarded a prestigious Cancer Research UK Clinician Scientist fellowship. As an active campaigner for raising awareness nationally of metastatic breast cancer (MBC), Professor Palmieri has appeared on national TV and radio including the BBC.

Working as a Medical Oncologist specialising in breast cancer, Professor Palmieri focuses his academic and clinical interests on endocrine therapy breast cancer, and in particular targeting the androgen receptor as well brain metastases secondary to breast cancer.

He is actively involved in developing and initiating translational and clinical research trials and is currently leading a number of studies including focused on brain metastasis including one investigating the use of cell free DNA within cerebrospinal fluid as well as neoadjuvant study investigating endocrine therapy in combination with palbociclib, trastuzumab and tucatinib in ER-positive, PgR-positive and HER2-positive breast cancer (3-PILLARS) and real world data studies. Following on from co-leading CCP-UK CANCER a national NIHR URI funded project which characterised COVID-19 in cancer patients, along with infectious disease colleagues they are working with the Secure Anonymised Information linkage (SAIL) Databank, in Wales to look at the impact of COVID in Welsh cancer patients.

He co-chairs the breast group for the Cheshire and Merseyside Cancer Alliance, and is a member of  the UK Breast Cancer Clinical Studies Group, and co-chairs Metastatic breast cancer. He has previously been a member of the NHS England Genomics Clinical Reference Group and expert cancer member of Department of Health's independent advisory group on use of antibodies/antiviral drugs in patients vulnerable to COVID-19.

He is the patient public involvement lead for the Liverpool Experimental Cancer Medicine Centre (ECMC). As a member of Breast International Group brain metastasis working group he is involved in developing studies for brain metastases at international level. He is actively involved in undergraduate teaching and is the speciality lead for oncology for the University to Liverpool Medical School and established the National Institute for Health and Care Research (NIHR) Academic Clinical Fellowship (ACF) scheme for medical oncology in Merseyside.

He co-developed and established the first ever UK meeting for patients with metastatic breast cancer. The first ‘secondary breast cancer summit’ saw 100 women and men living with SBC were hosed in Liverpool in July 2024, for 2 days of  talks and networking, with around 400 people attending on line. All places were fully funded, and the second one is due to take place in June 2025.

Alongside this he has co-developed and edited the book, ‘ABC of Cancer Care’ aimed at non-specialists and students, outlining the current management of cancer as well as explaining issues around survivorship and clinical trials. The second edition is currently being developed.

Imperial College Healthcare Trust

University of Southampton and University Hospital Southampton NHS Foundation Trust

Ninewells Hospital, Scotland

Mr Vassilis Pitsinis is a Consultant Breast Surgeon and Clinical Lead for Breast Surgery in NHS Tayside (Ninewells Hospital and Medical School) with an interest in Oncoplastic Surgery. He is also an Honorary Senior Clinical Lecturer in the University of Dundee Medical School.
His current research among other projects involves into breast cancer is focused on in a novel technique of replacing radioisotope and blue dye with fluorescence as localization for sentinel lymph node biopsy in early breast cancer. 
He has been elected as a Tayside Academic Health Science Partnership Clinical Fellow.  
He is the British Association of Breast Surgery (ABS) representative for Scotland and Medicolegal lead.

University College London Hospitals and Royal Free University Hospital

Dr Fharat Raja is a Consultant Medical Oncologist. She graduated from Oxford University and then undertook her postgraduate training at University College London Hospital and Mount Vernon Cancer centre. She was a Clinical Fellow at the MRC Clinical Trials Unit and University College London Cancer Clinical Trials Centre developing and running clinical trials.

University of Nottingham and University Hospitals of Derby and Burton

University of Naples Federico II

Nicola Rocco is a breast surgical oncologist and assistant professor at the University of Naples Federico II (Naples, Italy) since January 2022. He previously worked as Chief of the Breast Surgical Unit of the Malzoni Cancer Center - MACC (Avellino, Italy).

He obtained his Medical Degree at University Federico II of Naples in 2005 and the Specialization in General Surgery at the same University in 2012. He obtained a PhD in Advanced Biomedical and Surgical Therapies at the University of Naples in cooperation with the National Research Council, studying the potential applications of 3D-printing and regenerative medicine in the field of breast reconstruction.

He was Research Fellow at “Fondazione Umberto Veronesi” with the project “Engineered Breast Reconstruction”. He attended the Plastic Surgery Unit headed by Dr. Maurizio Bruno Nava at National Cancer Institute in Milan (Italy), perfectioning his skills in breast reconstruction. 

He also obtained a Master in Breast Oncoplastic Surgery at the University of Genova (Italy) and the Certificate of Competence in Breast Cancer at the University of Ulm (Germany).He is scientific director of G.Re.T.A. (Group for Reconstructive and Therapeutic Advancements) (https://greta.maurizionava.it)

He received the European Breast Surgical Oncology Certification from BRESO.He is a member of the Education and Training Committee (Breast Working Gorup) of the ESSO (European Society of Surgical Oncology).

He is a Graduate of the College of the European School of Oncology. He is member of the scientific committee of the MBN International Oncoplastic Breast Meeting and MBN Aesthetic Breast Meeting organized by Dr. Maurizio Bruno Nava in Milan since 2012. He organized International Meetings and Webinars as scientific Director of G.Re.T.A. since 2017.He is member of the Cochrane Collaboration. He is surgical editor for the Cochrane Breast Cancer Group at University of Sydney, Australia. He is author of more than 100 peer-reviewed scientific articles.

St Vincent's University Hospital

Ms Rutherford undertook her undergraduate education at the University of Glasgow (MBChB) which she completed in 2011. She completed her General Surgical Training with a specialist interest in Oncoplastic Breast Surgery in the West of Scotland.

Ms Rutherford has completed two fellowships:
-    Oncoplastic Fellowship at KK Women’s and Children’s Hospital and Singapore General Hospital, Singapore
-    National Oncoplastic TIG Fellowship at St Barts, St Barts NHS Trust, London, UK

Ms Rutherford was awarded both the ASGBI Gold Medal and G B Ong Medal for the most outstanding candidate in the FRCS examination in 2021. She was also awarded a merit for her performance in the European Board of Surgery Breast Examination (FEBS).

Ms Rutherford commenced as a Consultant Oncoplastic Breast Surgeon at St Vincent’s University Hospital in Dublin in August 2022. Her specialist area of interest is oncoplastic and reconstructive breast surgery including breast conserving surgery through the use of therapeutic mammoplasty and chest wall perforator flaps, as well as whole breast implant-based reconstruction.

King's College London

Elinor Sawyer is Professor of Clinical Oncology and Breast Cancer Genetics at King’s College London and Guy’s Cancer Centre. She trained as a clinician scientist at the London Research Institute.  Her PhD focused on the molecular genetics of phyllodes tumours. Her current research interests are genetic predisposition to breast cancer, particularly lobular breast cancer and DCIS, with a focus on identification of biomarkers that predict progression of LCIS and DCIS. She is a member of the Sloane Steering Committee (a national UK audit of screen detected DCIS) and leads on the molecular analyses of the UK DCIS samples in the CRUK Grand Challenge, PRECISION, and the application of these findings to clinical practice. She is on the Trials Management Group of three National UK radiotherapy studies (IMPORT–LOW, IMPORT–HIGH, Fast Forward) and is also involved in the translational studies associated with these trials.

Royal Cornwall Hospitals NHS Trust

Mr Max Seabrook is a surgical registrar in the South West deanery with a declared interest in Oncoplastic Breast Surgery, developed through experience at the Royal Devon and Exeter Hospital. His work has been published on oncoplastic surgery, surgical oncology and genotyping, as well as medical education—including robotic surgical training and the use of technology in teaching, which formed the basis of his Master’s thesis. He has presented at both national and international surgical conferences and is currently involved in research and innovation in surgical education, working towards a career in oncoplastic breast surgery.

Queen Elizabeth Hospital Birmingham

Professor Abeer Shaaban is a Consultant Pathologist at Queen Elizabeth Hospital Birmingham and Professor of Cancer and Genomic Sciences, University of Birmingham. She is Professional Clinical Advisor (PCA) for the UK NHS Breast Screening Programme and Pathology lead for the NHS Genomic Medicine Service Alliance (GMSA) for Central and South. 

She has published 210 peer reviewed publications and contributed to a number of guidelines including the WHO Blue Book for Genomic Syndromes 2023, the WHO Blue Book for Breast tumours 2019,  the International Collaboration on Cancer Reporting (ICCR)  DCIS dataset 2021, the RCPath Breast Pathology reporting guidelines (2023) and the European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO. Her research interests include HER2 low breast cancer, tissue biomarker analysis, ethnic diversity of breast cancer, neoadjuvant chemotherapy and endocrine therapy.

She led the NCRI Cellular and Molecular Pathology initiative Workstream 2 (Clinical Trials) and served as member of the RCPath, member of the Scientific Advisory Board of Breast Cancer Now and Committee member for the Pathological Society of Great Britain and Ireland.

Warrington and Halton NHS Trust

Leeds Teaching Hospital NHS Trust

Dr Nisha Sharma is Director of the breast screening programme for Leeds and Wakefield and a consultant breast radiologist. She is active in research and audit and is recognised as a national and international speaker. She developed the UK breast screening guidelines on how to manage high risk lesions. She is also involved in a number of trials looking to minimise over treatment and also support risk adapted screening. She is actively involved in studies involving artificial intelligence. She sits on a large number of committees and is audit lead for the British Society of Radiology. She is a clinical advisor for NHS England breast screening programme and professional clinical advisor for the breast screening quality assurance programme

Portsmouth Hospitals University NHS Trust

Edward St John is a consultant oncoplastic breast surgeon working at Portsmouth Hospitals University NHS Trust and an Honorary Associate Professor at the University of Portsmouth. He is the Co-founder and Chief Medical Officer of Concentric Health, an InnovateUK & SBRI supported platform for digital consent & enhanced shared decision making. Concentric is the most used clinical digital consent application in the UK. He is a member of the ABS Academic & Research Committee, the Partnership Lead of the Innovation Hub for the Royal College of Surgeons England, and an experienced NHS Clinical entrepreneur fellow. He is passionate about healthcare and effective, safe innovation. Amongst other skills he has domain expertise in consent & shared decision making, the evaluation of medical devices and digital health.

ICPV and Make 2nds Count

Lesley was a freelance communications consultant before she was diagnosed  ‘de novo’ with metastatic breast cancer (MBC) in 2014.   As part of her many treatments, including a lobectomy, she took part in a phase 1B clinical trial at the Beatson in Glasgow and stayed on that trial for 7 years.
Being so well on the trial enabled her to get involved in patient advocacy work, campaigning to get a better deal for metastatic breast cancer patients who often feel left behind when it comes to research, treatments and support.  
She has worked with the NCRI, ICGC-ARGO (genomics), CRUK and Breast Cancer Now.  She is also a member of ICPV and a trustee of a metastatic breast cancer charity, Make 2nds Count, which supports women and men through research, support and education  She attends the Breast Cancer Clinical Studies Group, is on the PRIMROSE and TARGET-National trial steering groups, involved in the Lancet Breast Cancer Commission and is a patient rep on the UKIBCS Organising Committee.
She feels strongly that more patients should be aware of, and have access to, clinical trials.  This could give them access to a new line of treatment, give them hope and also enable research.  As a result of her particular interest in research, through Make 2nds Count she has helped to deliver several unique research services for MBC patients.  These include a trial matching service for MBC patients and a large scale ‘scientific’ conference for patients.

Hillingdon Hospital NHS Trust

NHS Lothian

Rebecca Swan is a senior General Surgery Registrar with a goal of pursuing a career as an Oncoplastic Breast Surgeon. She graduated from the University of Aberdeen with Commendation and her postgraduate training has been based in the Edinburgh Breast Unit. Alongside her surgical training, she is interested in teaching and research. Recent studies include long-term outcomes of immediate lipofilling in breast conserving surgery, and survival after breast conserving surgery in multi-site breast cancer. She enjoyed completing the Introduction to Breast Ultrasound course with the University of East Anglia. 

St George’s Hospital

Worcestershire Royal Hospital

Steven Thrush is an experienced breast reconstructive and aesthetic surgeon who has been a Consultant Breast Surgeon in Worcester since 2004. He is passionate about education and has been involved with the the ABS (previously Royal College of Surgeons of England)  breast courses since 2005. He is also a module lead for the Oncoplastic Breast Masters Course run through University of East Anglia. He has lectured internationally and published numerous academic papers on breast surgery.

Royal Devon & Exeter Hospital

Rachel Tillett is a Consultant in Plastic and Oncoplastic Breast Surgery in Exeter, and was appointed in 2013. Having studied at Oxford University and St Mary’s, she completed plastic surgery training in the south west. This was followed by a National Breast TIG Fellowship in Exeter.

She performs her own resectional work alongside a DIEP practice,  other forms of total breast reconstruction, chest wall perforator flaps and all other oncoplastic techniques.

She is passionate about providing more patient access to chest wall perforator flaps and was the first surgeon to develop a practice in the south west.

Candiolo Cancer Institute FPO-IRCCS, Turin, Italy

Dr Toesca plays a leading role in Candiolo Comprehensive Cancer Center in Italy as Director of the
Breast Surgical Oncology Program. He maintains a busy clinical research program and is also a Principal Investigator for the Robotic Breast Cancer Surgery Program in Europe. Dr. Toesca leads the premier program to train Robotic breast cancer surgeons. He serves as a Professor on Master's Degree Course of Mastology in Madrid. Dr. Toesca is heavily involved with the Candiolo Comprehensive Cancer Center Network clinical
expansion in terms of assessment, benchmarking, and review of potential new partners and ongoing member hospital and programmatic relationships nationally and internationally. He is a regularly invited speaker at academic and international meetings and has authored or co-authored peer-reviewed scientific reports, editorials/commentaries, and text chapters

The Institute of Cancer Research

The Institute of Cancer Research

Sunderland/South Tyneside Foundation Trust

Since 2006, Caroline has served as a Breast Clinical Nurse Specialist (CNS) and is currently a committee member at NICE, along with being the Northern Nurse Representative for the ABS. Caroline previously worked as the Lead Lifestyle Advisor for The North of England Activity after Breast Cancer Trial, bringing her expertise to enhance post-treatment well-being. As a qualified Personal Trainer/ Exercise Referrer/ Cancer Rehabilitation Practitioner, she has a specialist interest in cancer recovery, and currently run Virtual Clinics supporting Cancer Prehab/Rehab. Caroline is currently on a two-year secondment as the Macmillan Lead Practitioner for Living with Cancer in Sunderland/South Tyneside, with the primary objective of making a positive impact on those facing the challenges of living with cancer.

Mummy's Star

Pete is the founder and CEO of the charity Mummy’s Star, set up in 2013 in memory of his wife Mair, to offer support to women/birthing people diagnosed with cancer during pregnancy, within 12 months of having a baby or experiencing pregnancy/baby loss. 

He is passionate about ensuring that women/birthing people have the same informed choice in pregnancy that they would have without their diagnosis, and works with universities, hospitals and cancer centres nationwide delivering training and education to help improve knowledge about this area, sharing case studies and the various examples of practice that help the families they support on a day to day basis, including advocating for timely and equal access to donor breast milk for families having the choice to feed removed due to treatment/surgery.

The charity’s campaign work has included ‘See the Symptom’ launched in 2022 to push for greater and more timely considerations of cancer symptoms during pregnancy and post-natally, to offer a greater range of options for families upon diagnosis.

He also works in men’s mental health to seek better holistic care for families, especially where serious illness occurs around pregnancy to ensure partners are better supported in the short, medium, and long term.

Prior to the charity’s formation, he worked in the housing and regeneration sector for 10 years, developing and delivering a variety of youth, health, and environmental improvement projects in some of Greater Manchester’s most deprived communities.

Manchester University NHS Foundation Trust

Chloe Wright is Consultant Oncoplastic and Chest Contouring Breast Surgeon at Manchester Foundation NHS Trust, where she is service lead for their gender affirming mastectomy service. Manchester is the biggest NHS provider of this surgery, performing more than 350 cases in the last year. Alongside oncoplastic breast practice, Chloe's specialist skills are in delivery of gender affirming top surgery for trans masculine and non-binary people; and the support of transgender and non-binary people in breast services.

University of Sheffield

Lynda Wyld underwent surgical training in the UK, spending time in Sheffield, Nottingham and Manchester. She did her PhD at the University of Sheffield. She was appointed to an academic post at the University of Sheffield in 2002 and is now Professor of Surgical Oncology. Her clinical interest is the management of breast cancer in older women and she practices as a Consultant Oncoplastic Breast Surgeon at Doncaster Teaching Hospitals in the UK. Her main research interest is in age related inequalities in cancer surgery where she has led projects to improve outcomes and develop decision aids for older women with breast cancer. Her other career focus has been to develop training in breast cancer surgery and in particular to see the development of breast surgery as a specialty in its own right. She is a Trustee of the ABS and is the current secretary and President Elect of European Breast Exam Board.

University Hospital Southampton